Best CAR T-cell therapy doctors: TOP 37 doctors

Dr. Ram Ron specializes in CAR T-cell therapy at Sourasky Medical Center (Ichilov), bringing extensive expertise to this advanced treatment.

• Focused on cutting-edge cellular therapies
• Works at a leading medical center for oncology
• Dedicated to personalized treatment approaches

Dr. Ron Ram has performed several hundred stem cell transplants and published over 30 scientific articles in hematology and oncology.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Fellowship-trained at New York Medical College
• Specializes in hematologic malignancies and transplants
• Academic contributor with textbook chapter authorship

Head of Pediatric Oncohematology at Dana Dwek Children's Hospital – Dr. Ronit El Hasid specializes in bone marrow and blood transplants for children.

• Performed 300+ transplant procedures
• Published 50+ medical papers
• Presented research at 40+ conferences
• Fellow of American Association for Hematology
• Trained at City of Hope Hospital in Los Angeles

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Professor Bulent Eser specializes in hematology with a focus on cutting-edge treatments like CAR T-cell therapy at Medical Park Antalya Hospital Complex.

• Over 36 years of experience of experience in hematology and internal medicine
• Member of the European Group for Blood and Marrow Transplantation
• Professor at Erciyes University, Faculty of Medicine
• Active in clinical research and advanced hematologic treatments

Professor Bozkurt trained in pediatric oncology at top US and Turkish hospitals, with extensive experience in stem cell therapy. As Clinical Director of Pediatric Hematology-Oncology at Medical Park Bahcelievler, he leads one of Turkey's top units.

• Expert in pediatric bone marrow transplantation and CAR T-cell therapies
• Specialized training at Cincinnati Children's Hospital and Harvard's Dana-Farber Cancer Institute
• Published 40+ research papers on childhood cancers and stem cell therapies
• Vice Director of the Stem Cell Transplant Unit at Medical Park
• Active member of EBMT and SIOP – key groups advancing cellular therapies

Specialist in bone marrow transplantation at SJD Barcelona Children's Hospital, focusing on pediatric hematology.

• Expertise in CAR T-cell therapy for children
• Works at one of Spain's leading pediatric hospitals
• Dedicated to advanced treatments for hematological conditions

Dr. Francesc Cobo Valien specializes in oncohematology with a focus on lymphoma and leukemia, backed by extensive research and prestigious awards.

• Graduated from the University of Barcelona in 1990
• Specialized in oncohematology at Hospital Clínic de Barcelona
• Recipient of multiple research grants and awards
• Expert in CAR T-cell therapy for hematologic malignancies

Specializes in CAR T-cell therapy at Lu Daopei Hematology Hospital, a leading center for hematologic treatments.

• Focuses on innovative cellular therapies
• Works at a renowned hematology hospital
• Expert in managing complex hematologic cases

Dr. Michael Shapira specializes in Bone Marrow Transplantation at Sourasky Medical Center (Ichilov), with extensive experience in the field.

• Graduated from Hebrew University Medical School in 1999
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in Bone Marrow Transplantation at Hadassah
• Fluent in English and Hebrew

Dr. Kodchanut specializes in CAR T-cell therapy at Intrarat Hospital, leveraging advanced hematology training to improve patient outcomes.

• Graduated with honors from Naresuan University Hospital's MD program
• Thai Board certified hematologist with specialized fellowship at Thammasat University
• Pioneer in hematology services at Huahin Hospital since 2020
• Co-author of research on cancer-associated venous thromboembolism risk models

Director of pediatric hematology oncology at Sourasky Medical Center – specializes in CAR T-cell therapy for children with blood disorders and sarcomas.

• Senior pediatrician at Children's Hospital Dana
• Trained at Rizzoli Orthopaedic Institute – one of the world's leading centers for bone cancer
• Member of ISPHO – Israel's pediatric hemato-oncology association
• Coordinates sarcoma treatment programs for children

With 34 years of experience of experience, Dr. Aviv specializes in CAR T-cell therapy at Sourasky Medical Center (Ichilov Clinic).

• Focuses exclusively on oncohematology
• Extensive experience with advanced cellular therapies
• Practices at one of Israel's leading medical centers

Dr. Yair has made significant contributions to hematology, particularly in chronic lymphocytic leukemia, with numerous awards and published research.

• Recipient of multiple prestigious awards including the Klitzberg Oncology Award
• Member of both Israeli and American Hematology Associations
• Extensive training in hematology at Tel Aviv Medical Center
• Active in research with grants from the Israeli Science Foundation

Dr. Mustafa Serkan Alemdar specializes in CAR T-cell therapy at Medical Park Antalya Hospital Complex, with a strong background in medical oncology.

• Completed medical oncology training at Akdeniz University
• Over 20 years of experience of experience in medical oncology
• Worked at top hospitals including Akdeniz University Hospital
• Dedicated to advancing cancer treatment through innovative therapies

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.